Tags : Potential

Eli Lilly Initiates the World’s First Clinical Study to Evaluate

Shots: Eli Lilly reported that first patients have been dosed in a P-I study of LY-CoV555, the first Ab emerge from the collaboration b/w Lilly & AbCellera to create Ab therapies against COVID-19. The P-I J2W-MC-PYAA study aims to evaluate the safety, tolerability, PK/PD of LY-CoV555 following a single dose administered to participants hospitalized for […]Read More

Merck Collaborates with ISB to Evaluate the Mechanism of COVID-19

Shots: Merck allied with ISB and a consortium of companies to investigate the molecular mechanisms of SARS-CoV-2 Infection and to identify new targets for potential COVID-19 therapeutics and vaccines The collaboration supports the trial led by ISB and Swedish Medical Center in Seattle. By collecting blood and nasal swabs at different times following a patient’s […]Read More

Fresenius Kabi Voluntary Recalls Two Lots of Fluorouracil Injection Due

Shots: Fresenius Kabi voluntarily recalls two lots of Fluorouracil Injection with a lot number 6120341 and 6120420 to the consumer level due to the presence of glass particulate, distributed between Dec 06, 2018 & Feb 20, 2019 Fresenius Kabi notifies its distributors and customers via letter to immediately check their stock and discontinue the utilization […]Read More